Diagnosis dan Tatalaksana Tinea Imbrikata

Penulis

  • David Dwiadiputra Hartanto Alumnus Fakultas Kedokteran Universitas Tarumanagara, Jakarta, Indonesia

DOI:

https://doi.org/10.55175/cdk.v47i10.546

Kata Kunci:

Dermatofitosis, tinea imbrikata, trichophyton concentricum

Abstrak

Tinea imbrikata merupakan dermatofitosis superfisial kronik yang sering kambuh, terutama mengenai individu di lingkungan primitif dan terisolasi. Penyakit ini disebabkan oleh dermatofita antropofilik, yaitu Tricophyton concentricum. Indonesia masih termasuk daerah endemis. Penularan melalui kontak erat dengan orang terinfeksi. Faktor predisposisi termasuk faktor kelembapan, keturunan, dan imunologi. Terapi terbaik menggunakan terbinafine dan griseofulvin oral dengan kombinasi keratolitik topikal. Terapi adekuat, eliminasi faktor predisposisi, dan sumber infeksi penting untuk mengurangi kekambuhan.

Tinea imbricata is a chronic and often recurrent superficial dermatophytosis, mainly affects individuals living in primitive and isolated environment. Tinea imbricata caused by anthropophilic dermatophyte, Trichophyton concentricum. Indonesia is still an endemic area. Transmission is through close contact with an infected person. Predisposing factors include humidity, heredity, and immunology. Best therapy is oral terbinafine and griseofulvin combined with topical keratolytic. Adequate therapy, elimination of predisposing factors, and source of infection are important to reduce recurrence.

Unduhan

Data unduhan belum tersedia.

Referensi

Leung AKC, Leong KF, Lam JM. Tinea imbricata. J Pediatr. 2018 Sep;200:285-285.e1.

Leung AKC, Leong KF, Lam JM. Tinea imbricata: An Overview. Curr Pediatr Rev. 2019 Feb 7.

Veraldi S, Giorgi R, Pontini P, Tadini G, Nazzaro G. Tinea imbricata in an Italian child and review of the literature. Mycopathologia. 2015 Dec;180(5-6):353-7.

Bramono K. Chronic recurrent dermatophytosis in the tropics: studies on tinea imbricata in indonesia. Korean J Med Mycol. 2012;17(1): 1-7.

Bonifaz A, Vázquez-González D. Tinea imbricata in the americas. Curr Opin Infect Dis. 2011;24(2):106-11.

Bonifaz A, Archer-Dubon, Saúl A. Tinea imbricata or Tokelau. Int J Dermatol. 2004;43(7):506-10.

Veraldi S, Giorgi R, Pontini P, Tadini G, Nazzaro G. Tinea Imbricata in an Italian Child and Review of the Literature. Mycopathologia. 2015;180(5-6):353-7.

Zawar V, Chuh A. J Eur Acad Dermatol Venereol. Pityriasis versicolor imbricata--overlapping parallel scales in a novel variant of pityriasis versicolor. 2008;22(9):1143-5.

Wingfield AB, Fernandez-Obregon AC, Wignall FS, Greer DL. Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole. Br J Dermatol. 2004;150(1):119-26.

Burns C, Valentine J. Tinea Imbricata. N Engl J Med. 2016;375(23):2272

Diterbitkan

2020-12-01

Cara Mengutip

Hartanto, D. D. (2020). Diagnosis dan Tatalaksana Tinea Imbrikata. Cermin Dunia Kedokteran, 47(10), 742–744. https://doi.org/10.55175/cdk.v47i10.546

Terbitan

Bagian

Articles